Method for Rapid Labeling of Waste Sludge from a Food Factory with 15N-Glycine and Evaluation of N Use Using Komatsuna (Brassica rapa Var. perviridis) by Mizuho Miura-Ido, Yuzuri Iwamoto, Hiroi Kouya, Yoshihiko Takahashi, Amjad Hassan, Norikuni Ohtake, Hidetaka Hori, Takuji Ohyama

“…To search movement of N from the SF-PMM to plants, we developed a new method to label small amounts of SF-PMM with 15N-glycine. 50 L of wastewater from a food factory was incubated with 1 L of active sludge and 3 g of 15N-glycine (98 atom% 15N), and 175 g of labeled sludge was obtained in a day. …”
Get full text

A non-randomised open-label exploratory ‘window of opportunity’ study of TG02 treatment in patients with locally advanced primary and recurrent RAS mutant colorectal cancer by Sara Roth, Kasmira Claire Wilson, Robert George Ramsay, Catherine Mitchell, Shienny Sampurno, Toan Duc Pham, Joseph Cherng Huei Kong, Stephen Q. Wong, Alexander Graham Heriot, Sanjeev Deva, Matthew Burge, Cecilie Sverdrup, Anne-Sophie Moller, Lukasz Kuryk, Jon Amund Eriksen, Magnus Jaderberg, John Raymond Zalcberg, Michael Michael

Get full text

Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial by M Kanimozhi, Manisha Bisht, Ravikant, Arkapal Bandyopadhyay, Manisha Naithani, Shailendra Handu

“…Methodology: This 12-week open-label, parallel-group, randomized controlled trial was conducted among Indian people with type 2 diabetes mellitus and on metformin monotherapy with poor glycemic control (glycated hemoglobin >7% or 53 mmol/mol). …”
Get full text

The impact of price and image warnings on the social perception of gifting cigarettes in China by Guang Xu, Yibin Shi, Kecheng Du, Gang Wang, Liyun Wu

Subjects: Get full text

Synthesis of trehalose-based chemical tools for the study of the mycobacterial membrane by Lesur, Emilie, Rollando, Paulin, Guianvarc’h, Dominique, Bourdreux, Yann

Subjects: Get full text

Noms, étiquette(s) et identités dans Persuasion, de Jane Austen by Marie-Laure Massei

Subjects: Get full text

Advancing precision cancer immunotherapy drug development, administration, and response prediction with AI-enabled Raman spectroscopy by Jay Chadokiya, Kai Chang, Saurabh Sharma, Jack Hu, Jennie R. Lill, Jennifer Dionne, Jennifer Dionne, Jennifer Dionne, Amanda Kirane

Subjects: Get full text

Are consumers knowledgeable about neonicotinoid insecticides and pollinator-friendly plants? by Hayk Khachatryan, Xuan Wei, Alicia L. Rihn

Subjects: Get full text

Is it Possible to Produce Carrier-Free Fruit and Vegetable Powders by Spray Drying? by Alicja Barańska, Aleksandra Jedlińska, Katarzyna Samborska

Subjects: Get full text

Metasurface-Enabled Microphotonic Biosensors via BIC Modes by Francesco Dell’Olio

Subjects: Get full text

Are consumers knowledgeable about neonicotinoid insecticides and pollinator-friendly plants? by Hayk Khachatryan, Xuan Wei, Alicia L. Rihn

Subjects: Get full text

Case Series Review on Use of Topical Timolol in the Treatment of Superior Oblique Myokymia by Victoria Alexis Smerdon, Joanne Adeoye, Alison Rowlands

Subjects: Get full text

Robotization of Miniature-Scale Radio-Controlled Excavator: A New Medium for Construction- Specific DNN Data Generation by Seyedeh Fatemeh Saffari, Daeho Kim, Byungjoo Choi

Subjects: “…Automated labeling…”
Get full text

Design and implementation of routing strategy based on terminal trust by Ansheng YIN, Shunyi ZHANG

Subjects: Get full text

Comparison of the commodity certification systems in the European Union and in the Eurasian Economic Union by Valerii Kardanov, Denis Stoikov

Subjects: Get full text

Data-Driven Bearing Fault Diagnosis of Microgrid Network Power Device Based on a Stacked Denoising Autoencoder in Deep Learning and Clustering by Fast Search without Data Labels by Fan Xu, Xin Shu, Xin Li, Xiaodi Zhang

Get full text

C-reactive protein testing in primary care and antibiotic use in children with acute respiratory tract infections in Kyrgyzstan: an open-label, individually randomised, controlled trialResearch in context by Elvira Isaeva, Joakim Bloch, Azamat Akylbekov, Robert L. Skov, Anja Poulsen, Jørgen A.L. Kurtzhals, Susanne Reventlow, Nandini Sreenivasan, Maamed Mademilov, Volkert D. Siersma, Talant Sooronbaev, Jesper Kjærgaard, Rune M. Aabenhus

“…Methods: In this open label individually randomised controlled trial, children aged 6 months to 12 years with ARTI in primary care settings were assigned to receive either standard care or standard care plus CRP testing. …”
Get full text

Label-Free Detection of Human Serum Using Surface-Enhanced Raman Spectroscopy Based on Highly Branched Gold Nanoparticle Substrates for Discrimination of Non-Small Cell Lung Cancer by Xiaowei Cao, Zhenyu Wang, Liyan Bi, Jie Zheng

“…In this study, a potential label-free serum test based on SERS spectroscopy was developed to analyze human serum for the diagnosis of the non-small cell lung cancer (NSCLC). …”
Get full text

An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers by Vinod K. Ramani, Srimonta Gayen, Radheshyam Naik

Get full text

HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction by Robin Chung, James C Moon, Alexander R Lyon, Charlotte H Manisty, Muhummad Sohaib Nazir, Malcolm Walker, Peter Kellman, Benjamin Dowsing, Daniel Chen, Jessica Artico, Mark Westwood, Hakim-Moulay Dehbi, Rebecca Roylance, Tom Crake, Peter Schmid, Arjun Ghosh, Maria Sol Andres, Joanna Pedra, Orla Worn

“…The Randomised Controlled Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction (HER-SAFE) aims to evaluate whether HFT can be safely withdrawn in non-high cardiovascular (CV) risk patients with ‘recovered’ HER2 CTRCD.Methods and analysis This is a multicentre, open-label randomised controlled trial investigating whether withdrawal of HFT is non-inferior to continuation in non-high CV risk, breast cancer survivors with recovered HER2 CTRCD after cancer treatment completion. …”
Get full text